The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. This year’s metric has recorded a Price increase of 210.84%. However, over the past six months, we’ve seen a weaker performance of 35.31%. The price of ARQT fallen by 76.14% over the last 30 days. And in the last five days, it has fallen by -8.31%.
Arcutis Biotherapeutics Inc saw a rather unpredictable run in, in terms of market performance. The company’s stock reached its highest point at $15.40 on 04/13/23, while the lowest price for the same duration was marked at $1.76 on 12/01/23.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
52-week price history of ARQT Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Arcutis Biotherapeutics Inc’s current trading price is -34.81% away from its 52-week high, while its distance from the 52-week low is 470.45%. The stock’s price range during this period has varied between$1.76 and $15.40. The Arcutis Biotherapeutics Inc’s shares, which operate in the Healthcare, saw a trading volume of around 3.52 million for the day, a figure considerably lower than their average daily volume of 6.29 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Arcutis Biotherapeutics Inc (ARQT) has experienced a quarterly rise of 356.36% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 971.97M and boasts a workforce of 296 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 4.47, with a change in price of +6.28. Similarly, Arcutis Biotherapeutics Inc recorded 5,155,411 in trading volume during the last 100 days, posting a change of +167.38%.
ARQT’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for ARQT stands at 2.32. Similarly, the long-term debt-to-equity ratio is also 2.31.
ARQT Stock Stochastic Average
As of today, Arcutis Biotherapeutics Inc’s raw stochastic average for the last 50 days stands at 75.32%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 63.33%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 72.16% and 73.92%, respectively.
